MedTrace Logo

Methotrexate and Statins With Methotrexate Alone in the Treatment of Rheumatoid Arthritis

NCT04177173 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-11-26

No results posted yet for this study

Summary

The objective of the study is to compare the efficacy of combination of Methotrexate and Statins with Methotrexate alone in the treatment of Rheumatoid Arthritis. It is hypothesized that adding statins to methotrexate for treatment of rheumatic arthritis will significantly suppress the disease activity as compared to methotrexate alone.

Conditions

  • Arthritis, Rheumatoid

Interventions

DRUG

Simvastatin 20 mg

improvement of disease activity

DRUG

Methotrexate 10 mg

improvement of disease activity

Sponsors & Collaborators

  • King Edward Medical University

    lead OTHER

Principal Investigators

  • Rabia Rathore, FCPS · Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2018-12-14
Completion
2018-12-14

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04177173 on ClinicalTrials.gov